Position in PRLD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$73,151,963
+$35,842,308 QoQ
Shares Held
13,724,571
+25.8% QoQ
Ownership
17.2%
of shares outstanding
% of Portfolio
1.45%
of 13F equity value
Holder Rank
#1
of 75 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in PRLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names. PRLD ranks #11 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
15,518,492 | $630,516,329 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
6,776,632 | $343,914,074 | |
| 3 | MBX |
MBX Biosciences, Inc.
|
3,428,736 | $189,266,227 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
2,209,400 | $118,578,498 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
2,555,877 | $112,433,029 | |
| 6 | CRVS |
Corvus Pharmaceuticals, Inc.
|
7,165,006 | $107,045,189 | |
| 7 | AVBP |
ArriVent BioPharma, Inc.
|
3,027,328 | $105,169,374 | |
| 8 | ARGX |
Argenx SE
|
92,880 | $86,171,277 |
All Filings in PRLD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,151,963 | 13,724,571 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $37,309,655 | 10,909,256 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $31,636,842 | 10,909,256 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $15,709,328 | 10,909,256 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,825,588 | 10,909,256 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,378,308 | 10,909,256 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $13,909,301 | 10,909,256 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $22,582,159 | 10,909,256 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $41,564,265 | 10,909,256 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $51,709,873 | 10,909,256 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $46,582,523 | 10,909,256 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $33,709,601 | 10,909,256 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $49,091,652 | 10,909,256 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $57,226,238 | 10,039,691 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $60,639,733 | 10,039,691 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $66,362,357 | 10,039,691 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $52,407,187 | 10,039,691 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $69,273,867 | 10,039,691 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $124,994,152 | 10,039,691 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $313,740,343 | 10,039,691 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $287,436,353 | 10,039,691 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $435,019,811 | 10,039,691 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,115,813,449 | 15,594,877 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $469,873,644 | 15,594,877 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||